Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium.
Nasreddine R, Yombi JC, Darcis G, Florence E, Allard SD, De Scheerder MA, Henrard S, Demeester R, Messiaen P, Ausselet N, Loeckx M, Delforge M, De Wit S; Belgian Research on AIDS and HIV Consortium (BREACH). Nasreddine R, et al. Among authors: de wit s, de scheerder ma. HIV Med. 2023 Mar;24(3):267-278. doi: 10.1111/hiv.13373. Epub 2022 Aug 8. HIV Med. 2023. PMID: 35938381
Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy.
Grint D, Peters L, Reekie J, Soriano V, Kirk O, Knysz B, Suetnov O, Lazzarin A, Ledergerber B, Rockstroh JK, Mocroft A; EuroSIDA in EuroCoord (European Coordinating Committee for the Integration of Ongoing Coordination Actions Related to Clinical and Epidemiological HIV Research). Grint D, et al. HIV Med. 2013 Jul;14(6):370-8. doi: 10.1111/hiv.12033. Epub 2013 Mar 27. HIV Med. 2013. PMID: 23534815 Free article.
Factors associated with the continuum of care of HIV-infected patients in Belgium.
Van Beckhoven D, Lacor P, Moutschen M, Piérard D, Sasse A, Vaira D, Van den Wijngaert S, Vandercam B, Van Ranst M, Van Wijngaerden E, Vandekerckhove L, Verhofstede C, Verbrugge R, Demeester R, De Wit S, Florence E, Fransen K, Delforge ML, Goffard JC, Goubau P. Van Beckhoven D, et al. Among authors: de wit s. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19534. doi: 10.7448/IAS.17.4.19534. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394043 Free PMC article.
Risk factors for HCV acquisition among HIV-positive MSM in Belgium.
Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, Kenyon C, Florence E, Buvé A. Apers L, et al. Among authors: de wit s. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):585-93. doi: 10.1097/QAI.0000000000000528. J Acquir Immune Defic Syndr. 2015. PMID: 25763786
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A, Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. Bernardino JI, et al. Among authors: de wit s. Lancet HIV. 2015 Nov;2(11):e464-73. doi: 10.1016/S2352-3018(15)00181-2. Epub 2015 Sep 30. Lancet HIV. 2015. PMID: 26520926 Clinical Trial.
583 results